PAREXEL International Corporation (NASDAQ:PRXL) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders.
|
(a)
|
On December 8, 2016, we held our 2016 annual meeting of
shareholders. |
|
(b)
|
At our 2016 annual meeting of shareholders, our
shareholders approved the following proposals by the votes specified below: |
|
1.
|
to elect the following persons to serve as directors for a
three-year term continuing until the annual meeting of shareholders in 2019 and until their successors are elected and qualified: |
|
Broker
|
||||||||||
|
Director Nominees
|
Class
|
Term Expires
|
For
|
Withheld
|
Non-Votes
|
|||||
|
A. Dana Callow, Jr.
|
III
|
42,905,385
|
3,457,189
|
3,466,931
|
||||||
|
Christopher J. Lindop
|
III
|
45,448,829
|
913,745
|
3,466,931
|
||||||
|
Josef H. von Rickenbach
|
III
|
45,503,555
|
859,019
|
3,466,931
|
|
2.
|
to approve, in an advisory vote, the compensation of our
named executive officers as presented in the proxy statement: |
|
Broker
|
||||||
|
For
|
Against
|
Abstain
|
Non-Votes
|
|||
|
44,867,990
|
1,387,978
|
106,606
|
3,466,931
|
|
3.
|
to ratify the selection of Ernst Young LLP as the Companys
independent registered public accounting firm for the fiscal year ending June 30, 2017: |
|
For
|
Against
|
Abstain
|
||
|
49,063,040
|
752,753
|
13,712
|
|
(c)
|
Not applicable.
|
About PAREXEL International Corporation (NASDAQ:PRXL)
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company’s PI segment provides information technology solutions. PAREXEL International Corporation (NASDAQ:PRXL) Recent Trading Information
PAREXEL International Corporation (NASDAQ:PRXL) closed its last trading session down -0.22 at 65.37 with 611,632 shares trading hands.
